The reading room
Questions worth
taking seriously.
Research and practical guides for the decisions that sit behind a prescription.
Best GLP-1 providers: twelve options, with the terms in view
A useful shortlist starts with three questions: what is the medicine, what will you actually pay, and who looks after you once it arrives?
Read the guide Cost & contractsThe monthly price is only the first line of a GLP-1 bill
A price can be accurate and still be the wrong number for your budget. Read the amount due, the supply purchased and the renewal choice together.
Read the guide Medication literacySame ingredient name, different approval status
Compounded semaglutide, branded semaglutide and an approved generic are not three ways of saying the same thing.
Read the guide Care checklistBefore you choose an online GLP-1 provider, follow the prescription
The website is the front door. Your prescriber, pharmacy and follow-up arrangements are the parts to examine.
Read the guide Cost comparisonPrice a full first quarter, not an introductory month
A simple three-month worksheet exposes the difference between care fees, medication charges and longer commitments.
Read the guide Care continuityEnding a membership still leaves a care decision
Cancellation, a pending pharmacy order and a treatment plan may follow three different timelines.
Read the guide Service comparisonWhat does “ongoing support” actually buy?
Translate a broad care promise into named professionals, reachable channels and specific responsibilities.
Read the guideA new evidence reference
Look beyond the ingredient name.
Browse the peptide library, examine each profile’s scope and follow its original sources.
From the research desk
What does the study establish?
Semaglutide: what tolerability claims mean
How reported episodes, symptom intensity and treatment stopping shape the meaning of a tolerability claim.
Read the research ↗Scientific analysisTirzepatide: symptoms and treatment claims
A reading guide for examining treatment claims, their reasoning, and the questions left open.
Read the research ↗Policy document review · October 29, 2026
Reading the October peptide policy before choosing care
Read the October documents beside the terms you saved, with a separate question for every claim.